NCT06782555: A Study of Evofosfamide in Combination With Zalifrelimab and Balstilimab
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 71 planned
- Started
- 8 Jan 2025
- Primary completion
- Oct 2027
- Arms
- Castration-resistant prostate cancer, Pancreatic cancer, Human papilloma virus-negative squamous cell carcinoma of the head and neck
- Results
- None posted
- 8 Jan 2025: Trial started
- 20 Jan 2025: Trial registered